Type to search

Diamyd Medical


Diamyd Medical

Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development.

Diamyd Medical develops the diabetes vaccine Diamyd®, an Antigen Based Therapy (ABT) based on the exclusively in-licensed GAD molecule. In-licensed technologies for GABA and Gliadin also have potential to become a key piece of the puzzle of a future solution to prevent, treat or cure autoimmune diabetes and other inflammation-related conditions.

Diamyd Medical’s share is traded on Nasdaq Stockholm First North, ticker DMYD B.

Associated People